GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lunit 328130.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

16,170

+4.66%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Lunit

Its shares trade on KOSDAQ under the ticker 328130.KQ. It has been listed since 21 July 2022. In the fiscal year to 31 December 2024, it reported revenue of ₩17.46bn and net income of ₩498.7m. At that date it held total assets of ₩16.90bn and shareholders' equity of ₩6.47bn.

Lunit, Inc. engages in providing software for medical diagnostic imaging service. The company is headquartered in Seoul, Seoul. The company went IPO on 2022-07-21. The firm is principally engaged in the development and supply of medical software such as cancer diagnostic aid solutions, cancer early detection solutions, cancer risk prediction solutions and others through artificial intelligence (AI) technologies.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Technology
Listed since
21 Jul 2022
Employees
293
Website
lunit.io ↗

Leadership

Pay as last reported

  • Mr. Anthony PaekCo-Founder, Executive Chairman, Chief Innovation Officer
  • Mr. Beomseok SuhChief Executive Officer
  • Mr. Sunggyun ParkCo-Founder, Chief Product Officer, Regulation Division Officer
  • Mr. Hyeonseong ParkChief Financial Officer
  • Ms. Teri ThomasChief Business Officer, Cancer Screening Group

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Headquartered in Seoul, South Korea
  • IPO completed on 2022-07-21
  • Focus on AI-driven medical diagnostic software

Weaknesses

  • Limited to health care sector focus
  • No specific employee count mentioned beyond 293
  • No details on market share or revenue

Opportunities

  • Growth in AI medical diagnostic solutions market
  • Expansion of cancer diagnostic aid services
  • Potential for international market entry

Threats

  • Competition in AI medical software sector
  • Regulatory challenges in health care industry
  • Dependence on AI technology advancements

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.